Prestige Wealth Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5K Sell
89
-416
-82% -$154K 0.01% 303
2026
Q1
$148K Buy
505
+13
+3% +$4.27K 0.03% 177
2025
Q4
$173K Sell
492
-128
-21% -$43.3K 0.03% 169
2025
Q3
$200K Sell
620
-2
-0.3% -$622 0.04% 172
2025
Q2
$242K Buy
622
+39
+7% +$15.7K 0.05% 157
2025
Q1
$254K Buy
583
+20
+4% +$8.03K 0.05% 146
2024
Q4
$208K Sell
563
-44
-7% -$18.4K 0.04% 158
2024
Q3
$316K Buy
607
+11
+2% +$5.88K 0.07% 132
2024
Q2
$323K Buy
596
+13
+2% +$6.87K 0.07% 114
2024
Q1
$302K Sell
583
-35
-6% -$17.4K 0.07% 127
2023
Q4
$291K Buy
618
+53
+9% +$24.5K 0.07% 121
2023
Q3
$246K Sell
565
-527
-48% -$239K 0.06% 121
2023
Q2
$485K Sell
1,092
-694
-39% -$320K 0.11% 85
2023
Q1
$821K Buy
1,786
+709
+66% +$337K 0.21% 56
2022
Q4
$552K Sell
1,077
-558
-34% -$283K 0.14% 75
2022
Q3
$743K Buy
1,635
+160
+11% +$76.6K 0.21% 52
2022
Q2
$712K Buy
1,475
+429
+41% +$212K 0.19% 54
2022
Q1
$514K Buy
1,046
+973
+1,333% +$445K 0.13% 80
2021
Q4
$34K Sell
73
-24
-25% -$10.1K 0.01% 300
2021
Q3
$36K Hold
97
0.01% 289
2021
Q2
$37K Sell
97
-1
-1% -$382 0.01% 273
2021
Q1
$35K Hold
98
0.01% 284
2020
Q4
$31K Sell
98
-14
-13% -$4.3K 0.01% 296
2020
Q3
$30K Buy
112
+3
+3% +$807 0.01% 305
2020
Q2
$29K Buy
109
+10
+10% +$2.67K 0.01% 286
2020
Q1
$22K Buy
99
+90
+1,000% +$24.5K 0.01% 266
2019
Q4
$3K Buy
9
+1
+13% +$275 ﹤0.01% 457
2019
Q3
$2K Buy
+8
New +$2.19K ﹤0.01% 481
2019
Q1
Sell
-127
Closed -$33K 683
2018
Q4
$33K Buy
+127
New +$34.9K 0.02% 230

Other funds holding ELV

Prestige Wealth Management Group's ELV Position: Q2 2026 in Review

Prestige Wealth Management Group reduced its Elevance Health (ELV) stake by 82% in Q2 2026, selling an estimated $154K and leaving 89 shares worth $34.5K. The position accounts for 0.01% of the portfolio, ranked #303.

Prestige Wealth Management Group first reported a position in ELV in Q4 2018 and has held it in 29 quarters since. The position peaked at $821K in Q1 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Prestige Wealth Management Group held 89 shares of Elevance Health worth $34.5K as of Q2 2026.
  • Prestige Wealth Management Group sold 416 Elevance Health shares in Q2 2026, an estimated $154K.
  • Elevance Health made up 0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #303 holding.
  • Prestige Wealth Management Group first reported a position in Elevance Health in Q4 2018 and has held it in 29 quarters since.
  • Prestige Wealth Management Group's Elevance Health position peaked at $821K in Q1 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.